These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 25640931)

  • 1. Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches.
    Phillips ML; Chase HW; Sheline YI; Etkin A; Almeida JR; Deckersbach T; Trivedi MH
    Am J Psychiatry; 2015 Feb; 172(2):124-38. PubMed ID: 25640931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder.
    Fonseka TM; MacQueen GM; Kennedy SH
    J Affect Disord; 2018 Jun; 233():21-35. PubMed ID: 29150145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical appraisal of neuroimaging studies of bipolar disorder: toward a new conceptualization of underlying neural circuitry and a road map for future research.
    Phillips ML; Swartz HA
    Am J Psychiatry; 2014 Aug; 171(8):829-43. PubMed ID: 24626773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural and neuroendocrine predictors of pharmacological treatment response in adolescents with depression: A preliminary study.
    Klimes-Dougan B; Westlund Schreiner M; Thai M; Gunlicks-Stoessel M; Reigstad K; Cullen KR
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():194-202. PubMed ID: 29100972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design.
    Trivedi MH; McGrath PJ; Fava M; Parsey RV; Kurian BT; Phillips ML; Oquendo MA; Bruder G; Pizzagalli D; Toups M; Cooper C; Adams P; Weyandt S; Morris DW; Grannemann BD; Ogden RT; Buckner R; McInnis M; Kraemer HC; Petkova E; Carmody TJ; Weissman MM
    J Psychiatr Res; 2016 Jul; 78():11-23. PubMed ID: 27038550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Neuroimaging-Based Biomarkers in Major Depression.
    Han KM; Ham BJ; Kim YK
    Adv Exp Med Biol; 2021; 1305():85-99. PubMed ID: 33834396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.
    Lam RW; Milev R; Rotzinger S; Andreazza AC; Blier P; Brenner C; Daskalakis ZJ; Dharsee M; Downar J; Evans KR; Farzan F; Foster JA; Frey BN; Geraci J; Giacobbe P; Feilotter HE; Hall GB; Harkness KL; Hassel S; Ismail Z; Leri F; Liotti M; MacQueen GM; McAndrews MP; Minuzzi L; Müller DJ; Parikh SV; Placenza FM; Quilty LC; Ravindran AV; Salomons TV; Soares CN; Strother SC; Turecki G; Vaccarino AL; Vila-Rodriguez F; Kennedy SH;
    BMC Psychiatry; 2016 Apr; 16():105. PubMed ID: 27084692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inflammatory cytokines: molecular biomarkers for major depressive disorder?
    Martin C; Tansey KE; Schalkwyk LC; Powell TR
    Biomark Med; 2015; 9(2):169-80. PubMed ID: 24524646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid modulation of depression: A focus on imaging studies.
    Rouine J; Callaghan CK; O'Mara SM
    Prog Brain Res; 2018; 239():229-252. PubMed ID: 30314568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human amygdala engagement moderated by early life stress exposure is a biobehavioral target for predicting recovery on antidepressants.
    Goldstein-Piekarski AN; Korgaonkar MS; Green E; Suppes T; Schatzberg AF; Hastie T; Nemeroff CB; Williams LM
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11955-11960. PubMed ID: 27791054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anhedonia in depression].
    Gaillard R; Gourion D; Llorca PM
    Encephale; 2013 Sep; 39(4):296-305. PubMed ID: 23937895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoaminergic function in major depression. A possibly helpful tool for choosing treatment strategy].
    Moeller O; Norra C; Gründer G
    Nervenarzt; 2006 Jul; 77(7):800-8. PubMed ID: 16437254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroimaging-based biomarkers for treatment selection in major depressive disorder.
    Dunlop BW; Mayberg HS
    Dialogues Clin Neurosci; 2014 Dec; 16(4):479-90. PubMed ID: 25733953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural correlates of dysfunctional emotion regulation in major depressive disorder. A systematic review of neuroimaging studies.
    Rive MM; van Rooijen G; Veltman DJ; Phillips ML; Schene AH; Ruhé HG
    Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 2):2529-53. PubMed ID: 23928089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks.
    Gadad BS; Jha MK; Czysz A; Furman JL; Mayes TL; Emslie MP; Trivedi MH
    J Affect Disord; 2018 Jun; 233():3-14. PubMed ID: 28709695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional MRI findings, pharmacological treatment in major depression and clinical response.
    Arnone D
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Apr; 91():28-37. PubMed ID: 30099082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder.
    Smagula SF; Wallace ML; Anderson SJ; Karp JF; Lenze EJ; Mulsant BH; Butters MA; Blumberger DM; Diniz BS; Lotrich FE; Dew MA; Reynolds CF
    J Psychiatr Res; 2016 Oct; 81():112-8. PubMed ID: 27438687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rethinking depression and the actions of antidepressants: uncovering the links between the neural and behavioral elements.
    Katz MM; Bowden CL; Frazer A
    J Affect Disord; 2010 Jan; 120(1-3):16-23. PubMed ID: 19735945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic Brain Network Biomarkers of Antidepressant Response: a Review.
    Dunlop K; Talishinsky A; Liston C
    Curr Psychiatry Rep; 2019 Aug; 21(9):87. PubMed ID: 31410661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine.
    Furey ML; Drevets WC; Szczepanik J; Khanna A; Nugent A; Zarate CA
    Int J Neuropsychopharmacol; 2015 Mar; 18(8):. PubMed ID: 25820840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.